According to a new analysis by Future Market Insights (FMI), the Global Softgel Capsules Industry is expected to develop significantly and reach an impressive worth of US$1.9 billion by 2032. By the end of 2022, the sector is estimated to be valued at around US$1.1 billion, and it is predicted to expand at a substantial compound annual growth rate (CAGR) of 6.0%.
According to a thorough investigation conducted by FMI, gelatin softgel capsules commanded a substantial market share of over 75.4% in 2021. The industry was valued at over US$1.7 billion in 2021, which set the stage for significant growth throughout the projection period.
The driving force behind this unprecedented growth is the escalating interest in the oral delivery of medications with low water solubility. The development of Soft Gelatin Capsules (SGCs) delivery systems has gained substantial traction, offering a promising solution to the challenges posed by low-solubility medications in the pharmaceutical pipeline.
Soft Gelatin Capsules provide a sophisticated delivery method, encapsulating drugs and facilitating the transport of active constituents to the systemic circulation. This innovative approach addresses formulation constraints, ensuring superior dose accuracy, homogeneity, manufacturing consistency, and product stability.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15724
This is crucial for drugs that are susceptible to oxidative and hydrolytic breakdown. The expanding cosmetics industry’s desire for soft gel capsules to supply cosmeceuticals in the form of capsules drives the growth of the worldwide soft gel capsules market.
The rising consumption of supplements in capsule form increases demand for soft gel capsules, propelling the global soft gel capsules market. The pharmaceutical industry’s use of soft gel capsules is also aided by improvements to the capsules’ outer shell and compatibility with the ingredients inside, which have become two of the market’s main growth drivers.
Owed to the aforementioned factors, the Global Softgel Capsules Industry is set to reach an estimated valuation of US$ 3.1 Bn in 2032.
Key Takeaways from Global Softgel Capsules Industry Study
- Gelatin softgel capsules are the leading segment as a product, and hold approximately 3% market share in 2021, owing to their property of increased bioavailability, and greater absorption.
- Type-A gelatin (pork skin) segment is set to lead in terms of raw material for softgel capsules with a projected market share of around 5% by 2032, owing to the high availability of porcine sources of raw material globally.
- By application, health supplements are leading in the Global Softgel Capsules Industry, and are expected to continue to do so with a projected CAGR of 5% during the forecasted years, as they are easy to swallow and disintegrate quickly.
- By end users, CMOs hold a dominant market share of 2% in the global market in 2021, owing to the lowered cost of production, and higher output.
- Oral softgels are leading the market as a route of administration, holding a share of around 7% in 2021, owing to higher patient preference.
- North America is considered the leading region with a global share of 7% in 2021, owed to a large number of available distributors for softgel capsules in the region.
Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-15724
“Rising prevalence of chronic diseases is promoting the adoption of softgel capsules with greater bioavailability, enhanced absorption, and a long shelf-life,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Global Softgel Capsules Industry Market Competition
The market for softgel capsules is fragmented, and there exist several contract manufacturing players within the market sphere. Key players promote market expansion through novel product launch activities along with acquisitions and collaborations.
- The delayed/enteric release softgel OptiGel® DR by Catalent was introduced in October 2020 for applications in pharmaceutical and nutraceutical applications.
- Sirio Pharma Company Limited announced in July 2022 that Sirio will purchase 80% of Best Pharmaceuticals, a contract manufacturer of nutraceuticals and dietary supplements.
Global Softgel Capsules Industry Key Companies Profiled
- Aenova Group GmbH
- Fuji Capsule Co., Ltd
- Sirio Pharma Company Limited
- Catalent, Inc
- EuroCaps Ltd
- Guangdong Yichao Biological Co., Ltd.
- Elnova Pharma
- Captek Softgel International Inc
- Hunan Er-Kang Pharmaceutical Co., Ltd
- Soft Gel Technologies Inc.
Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-15724
Key Segments Covered in Global Softgel Capsules Industry Research
By Product:
- Gelatin Softgel Capsules
- Vegetarian Softgel Capsules
By Raw Material:
- Type-A Gelatin (Pork Skin)
- Type-B Gelatin (Animal Bones & Skin)
- Fish Bone Gelatin
- Cellulose Derivatives
- Starch Material
By Application:
- Antacid & Antiflatulent Preparations
- Antianemic Preparations Hematinic Preparations)
- Anti-inflammatory Drugs
- Antibiotic & Antibacterial Drugs
- Cough & Cold Preparations
- Cardiovascular Therapy Drugs
- Health Supplements
- Vitamin & Dietary Supplements
- Other Therapeutic Applications
By End User:
- In-house Manufacturing
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Contract Manufacturing Organizations
By Route of Administration:
- Oral Softgels
- Suppositories
- Pessaries
- Twist off Softgels
- Others
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube